The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Self-citationSmolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Self-citation2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E., McNaughton, C., Osani, M., Shmerling, R. H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39480 · Cited by 2,777
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Self-citationBreedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,172
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E., McNaughton, C., Osani, M., Shmerling, R. H., et al. (2016) · Arthritis Care & Research · doi:10.1002/acr.22783 · Cited by 1,107
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Self-citationTofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
Self-citation
Cited by
Smolen, J. S., Landewé, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,710
Self-citationDiagnosis and Management of Rheumatoid Arthritis: A Review
Aletaha, D., & Smolen, J. S. (2018) · JAMA · doi:10.1001/jama.2018.13103 · Cited by 2,313
Self-citationInterleukin-6: designing specific therapeutics for a complex cytokine
Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Guimarães, P. O., Quirk, D., Furtado, R. H., Maia, L. N., Saraiva, J. F., Antunes, M. O., Kalil Filho, R., Junior, V. M., Soeiro, A. M., Tognon, A. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101643 · Cited by 435
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Solimani, F., Meier, K., & Ghoreschi, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02847 · Cited by 308
Metadata
- Authors
- Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Zhang, R., Takiya, L., Tatulych, S., Mojcik, C., Krishnaswami, S., Menon, S., Smolen, J. S., Adams, L., Ally, M. M., du Plooy, M. C., Louw, I. C., Nayiager, S., Nel, C. B., Nel, D., Reuter, H., Soloman, A. S., Spargo, C. E., Hall, S., Rischmueller, M., Sharma, S. D., Will, R. K., Youssef, P. P., Arroyo, C., Baes, R. P., Dulos, R. B., Hao, L. T., Lanzon, A. E., Lichauco, J. J. T., Mangubat, J. H., Ramiterre, E. B., Reyes, B. H. M., Tan, P. P., Choe, J.-Y., Kang, Y. M., Kwon, S. R., Lee, S.-H., Lee, S.-S., Yoo, D.-H., Lin, H.-Y., Luo, S.-F., Tsai, S.-T., Tsai, W.-C., Tseng, J.-C., Wei, C.-C. C., Asavatanabodee, P., Nantiruj, K., Nilganuwong, S., Uea-Areewongsa, P., Majstorovic, L. B., Bacic, S. M., Batalov, A. Z., Georgieva-Slavcheva, G., Mihailova, M., Nikolov, N. G., Penev, D. P., Spasov, Y. A., Stanimirova, K., Todorov, S., Toncheva, A. R., Yordanova, N., Mosterova, Z., Novosad, L., Prochazkova, L., Stehlikova, H., Stejfova, Z., Kiseleva, N., Pank, L., Savi, T., Alexandra, B.-G., Amital, H., Mevorach, D., Rosner, I. A., Mihailova, A., Stumbra-Stumberga, E., Basijokiene, V., Lietuvininkiene, V., Unikiene, D., Brzezicki, J., Dudek, A. M., Glowacka-Kulesz, M. B., Grabowicz-Wasko, B., Hajduk-Kubacka, S., Hilt, J., Hrycaj, P., Jeka, S., Kolasa, R., Krogulec, M., Mastalerz, H., Olak-Popko, A., Owczarek, E., Ruzga, Z., Walczak, A., Ancuta, C. I., Ancuta, I., Balanescu, A. R., Berghea, F., Bojin, S., Arvunescu, M. A. I., Ionescu, R. M., Mociran, E., Pavel, M., Rednic, S., Voie, A., Zainea, C. M., Bugrova, O. V., Demin, A., Ershova, O. B., Gavrisheva, I. A., Krechikova, D. G., Kuropatkin, G. V., Marusenko, I. M., Menshikova, I. V., Noskov, S. M., Rebrov, A. P., Smakotina, S. A., Yakushin, S. S., Zhilyaev, E., Ramos, J. J. A., Garcia, F. J. B., Nebro, A. F., Esteban, S. P., Burson, J. M. S., Sala, R. S., Ataman, S., Hizmetli, S., Kuru, O., Douglas, K. M., Emery, P., Moots, R. J., Ong, V. H., Sheeran, T. P., Faraawi, R. Y., Lessard, C., Mendoza, C. A., Avila-Armengol, H. E., Zapata, F. I. A., Irazoque-Palazuelos, F. C., Cecena, M. A. M., Pacheco-Tena, C. F., Rizo-Rodriguez, J. C., Rodriguez-Torres, I. M., Aelion, J. A., Caciolo, B. A., Calmes, J. M., Chatpar, P., Dayal, N., De Jesus, A., Dikranian, A. H., Diri, E., Fairfax, M. J., Fenton, I. F., Fleischmann, R. M., Gaylis, N. B., George, R. L., Halter, D. G., Hernandez, P., Hole, S. A., Hou, A. C., Huff, J. P., Kafaja, S., Kennedy, A. C., Kenney, H., Kimmel, S. C., Kirby, B. S., Kivitz, A. J., Legerton, C. W., Lindsey, S. M., Mallepalli, J. R., Mathews, S. D., Metyas, S. K., Mizutani, W. T., Najam, S., Nascimento, J. M., Pang, S. W., Patel, R. C., Poiley, J. E., Ramirez, C. E., Reddy, R., Rehman, Q., Schnitz, W. M., Scoville, C. D., Shergy, W. J., Silverfield, J. C., Singhal, A. K., Smallwood-Sherrer, Y. R., Songcharoen, S. N., Stack, M. T., Stohl, W., Su, T.-I. K., Udell, J., Waraich, S., Weidmann, C. E., Wei, N., Wiesenhutter, C. W., Winkler, A. E., Zagar, K. E., Berman, A., Mysler, E. F., Hidalgo, R. A. P., Venarotti, H. O., Sariego, I. A. G., Calabresse, R. E. J., Ruiz-Tagle, J. I. V., Vargas, L. F. M. B., Berrocal, A. E., Portocarrero, M. G. L., Jesus, F., & Pena, R.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 390
- Issue
- 10093
- Pages
- 457-468
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2626892937
- Cited by
- 499
- References
- 27
- FWCI
- 38.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(17)31618-5
- The paper
- Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Zhang, R., Takiya, L., Tatulych, S., Mojcik, C., Krishnaswami, S., Menon, S., Smolen, J. S., Adams, L., Ally, M. M., du Plooy, M. C., Louw, I. C., . . . Pena, R. (2017). Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(17)31618-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.